← Back to headlines
Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline
Eli Lilly is reportedly considering re-entering the bidding process for Abivax, contingent on whether AstraZeneca fails to meet its acquisition deadline.
14 Mar, 03:30 — 14 Mar, 03:30
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
It was announced how much Musk's wealth has grown due to SpaceX's IPO
16m ago
Ghana Stock Exchange Maintains Positive Momentum Amidst Stock Losses
22m ago
This welder became a millionaire. "I had no idea it would grow to such proportions"
24m ago